BRIDGEWATER, N.J., Oct. 15, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its...
Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025
Seeking Alpha / 22 hours ago 2 Views
Comments